Pan Mersey
Area Prescribing Committee
 
back
8 Malignant disease and immunosuppression

Review date: January 2022

Non-formulary drugs: Any drug or formulation not listed in the formulary is deemed to be non-formulary.

Off-label use: Drugs are included in the formulary for their licensed indications – where inclusion of off-label use is considered to be included in the formulary this is specifically stated in the formulary entry for the drug N.B. also see Paediatrics note below.

Paediatrics: Drugs are included in the formulary for paediatric use for their BNF for Children recommended indications (indicated by symbol View childrens BNF) which may be off-label, unless otherwise stated. All drugs are deemed to have the same RAG status as they have for adults unless stated otherwise.

NHS England Specialised Commissioning
Drugs carrying the NHS England logo are commissioned by them. Links to key documents, national programmes of care, and clinical reference groups are found below.

NHSE NHS England Specialised Commissioning: Key documents

NHSE NHS England Specialised Commissioning: National programmes of care and clinical reference groups

Medications which are indicated for medically assisted reproduction, including ovulation induction (e.g. clomifene, letrozole and tamoxifen) and assisted reproduction, such as In Vitro Fertilisation or Ex Vitro Fertilisation (e.g. gonadotrophins) are restricted to use by specialist secondary care physicians, and are categorised as RED drugs for these purposes.

08-03-04-03 Somatostatin analogues

Octreotide
Formulary
Injection 50 micrograms/mL,
100 micrograms/mL, 200 micrograms/mL,
500 micrograms/mL;
Depot preparation 10mg, 20mg, 30mg

REDOctreotide is RED for acromegaly and neuroendocrine tumour.

Amber Initiated  Octreotide is AMBER Initiated in palliative care, although in some circumstances may be initated in primary care

NHS NHSE commissioned drug - see Specialised Commissioning: Key documents

Red View adult BNF  View SPC online
Pasireotide
Formulary

Injection 300 micrograms/mL, 600 micrograms/mL, 900 micrograms/mL

Powder and solvent for suspension for injection 10mg, 20mg, 30mg

Pasireotide for the treatment of Cushings Disease and acromegaly
NHS NHSE commissioned drug - see Specialised Commissioning: Key documents

Link  NHS England Key Documents
 

Red View adult BNF  View SPC online
Lanreotide
Formulary
Injection 30mg, 60mg, 90mg, 120mg

REDLanreotide is RED for acromegaly and neuroendocrine tumour

NHS NHSE commissioned drug - see Specialised Commissioning: Key documents

Red View adult BNF  View SPC online